213 related articles for article (PubMed ID: 26427042)
1. Targeted therapy for Epstein-Barr virus-associated gastric carcinoma using low-dose gemcitabine-induced lytic activation.
Lee HG; Kim H; Kim EJ; Park PG; Dong SM; Choi TH; Kim H; Chong CR; Liu JO; Chen J; Ambinder RF; Hayward SD; Park JH; Lee JM
Oncotarget; 2015 Oct; 6(31):31018-29. PubMed ID: 26427042
[TBL] [Abstract][Full Text] [Related]
2. Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas.
Feng WH; Hong G; Delecluse HJ; Kenney SC
J Virol; 2004 Feb; 78(4):1893-902. PubMed ID: 14747554
[TBL] [Abstract][Full Text] [Related]
3. Application of a patient-derived xenograft model in cytolytic viral activation therapy for nasopharyngeal carcinoma.
Hsu CL; Kuo YC; Huang Y; Huang YC; Lui KW; Chang KP; Lin TL; Fan HC; Lin AC; Hsieh CH; Lee LY; Wang HM; Li HP; Chang YS
Oncotarget; 2015 Oct; 6(31):31323-34. PubMed ID: 26416517
[TBL] [Abstract][Full Text] [Related]
4. Cytolytic virus activation therapy and treatment monitoring for Epstein-Barr virus associated nasopharyngeal carcinoma in a mouse tumor model.
Novalić Z; Verkuijlen SAWM; Verlaan M; Eersels JLH; de Greeuw I; Molthoff CFM; Middeldorp JM; Greijer AE
J Med Virol; 2017 Dec; 89(12):2207-2216. PubMed ID: 28853217
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir.
Hui KF; Cheung AK; Choi CK; Yeung PL; Middeldorp JM; Lung ML; Tsao SW; Chiang AK
Int J Cancer; 2016 Jan; 138(1):125-36. PubMed ID: 26205347
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy induces lytic EBV replication and confers ganciclovir susceptibility to EBV-positive epithelial cell tumors.
Feng WH; Israel B; Raab-Traub N; Busson P; Kenney SC
Cancer Res; 2002 Mar; 62(6):1920-6. PubMed ID: 11912175
[TBL] [Abstract][Full Text] [Related]
7. Cordycepin enhances Epstein-Barr virus lytic infection and Epstein-Barr virus-positive tumor treatment efficacy by doxorubicin.
Du Y; Yu J; Du L; Tang J; Feng WH
Cancer Lett; 2016 Jul; 376(2):240-8. PubMed ID: 27063964
[TBL] [Abstract][Full Text] [Related]
8. Activation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignancies.
Westphal EM; Blackstock W; Feng W; Israel B; Kenney SC
Cancer Res; 2000 Oct; 60(20):5781-8. PubMed ID: 11059774
[TBL] [Abstract][Full Text] [Related]
9. The Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral production.
Meng Q; Hagemeier SR; Fingeroth JD; Gershburg E; Pagano JS; Kenney SC
J Virol; 2010 May; 84(9):4534-42. PubMed ID: 20181711
[TBL] [Abstract][Full Text] [Related]
10. Induction of Epstein-Barr virus kinases to sensitize tumor cells to nucleoside analogues.
Moore SM; Cannon JS; Tanhehco YC; Hamzeh FM; Ambinder RF
Antimicrob Agents Chemother; 2001 Jul; 45(7):2082-91. PubMed ID: 11408227
[TBL] [Abstract][Full Text] [Related]
11. A Mechanism-Based Targeted Screen To Identify Epstein-Barr Virus-Directed Antiviral Agents.
Li X; Akinyemi IA; You JK; Rezaei MA; Li C; McIntosh MT; Del Poeta M; Bhaduri-McIntosh S
J Virol; 2020 Oct; 94(21):. PubMed ID: 32796077
[TBL] [Abstract][Full Text] [Related]
12. Cytolytic virus activation therapy for Epstein-Barr virus-driven tumors.
Wildeman MA; Novalic Z; Verkuijlen SA; Juwana H; Huitema AD; Tan IB; Middeldorp JM; de Boer JP; Greijer AE
Clin Cancer Res; 2012 Sep; 18(18):5061-70. PubMed ID: 22761471
[TBL] [Abstract][Full Text] [Related]
13. The Role of Epigenetic Regulation in Epstein-Barr Virus-Associated Gastric Cancer.
Nishikawa J; Iizasa H; Yoshiyama H; Nakamura M; Saito M; Sasaki S; Shimokuri K; Yanagihara M; Sakai K; Suehiro Y; Yamasaki T; Sakaida I
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757548
[TBL] [Abstract][Full Text] [Related]
14. Adenosine Induces EBV Lytic Reactivation through ADORA1 in EBV-Associated Gastric Carcinoma.
Choi SJ; Ryu E; Lee S; Huh S; Shin YS; Kang BW; Kim JG; Cho H; Kang H
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30875759
[No Abstract] [Full Text] [Related]
15. Ganciclovir augments the lytic induction and apoptosis induced by chemotherapeutic agents in an Epstein-Barr virus-infected gastric carcinoma cell line.
Ji Jung E; Mie Lee Y; Lan Lee B; Soo Chang M; Ho Kim W
Anticancer Drugs; 2007 Jan; 18(1):79-85. PubMed ID: 17159505
[TBL] [Abstract][Full Text] [Related]
16. Interfering with cellular signaling pathways enhances sensitization to combined sodium butyrate and GCV treatment in EBV-positive tumor cells.
He Y; Cai S; Zhang G; Li X; Pan L; Du J
Virus Res; 2008 Jul; 135(1):175-80. PubMed ID: 18455826
[TBL] [Abstract][Full Text] [Related]
17. Lytic induction and apoptosis of Epstein-Barr virus-associated gastric cancer cell line with epigenetic modifiers and ganciclovir.
Jung EJ; Lee YM; Lee BL; Chang MS; Kim WH
Cancer Lett; 2007 Mar; 247(1):77-83. PubMed ID: 16647201
[TBL] [Abstract][Full Text] [Related]
18. Induction of the Epstein-Barr virus thymidine kinase gene with concomitant nucleoside antivirals as a therapeutic strategy for Epstein-Barr virus-associated malignancies.
Faller DV; Mentzer SJ; Perrine SP
Curr Opin Oncol; 2001 Sep; 13(5):360-7. PubMed ID: 11555713
[TBL] [Abstract][Full Text] [Related]
19. Arginine butyrate-induced susceptibility to ganciclovir in an Epstein-Barr-virus-associated lymphoma.
Mentzer SJ; Fingeroth J; Reilly JJ; Perrine SP; Faller DV
Blood Cells Mol Dis; 1998 Jun; 24(2):114-23. PubMed ID: 9628848
[TBL] [Abstract][Full Text] [Related]
20. Olaparib-induced Apoptosis Through EBNA1-ATR-p38 MAPK Signaling Pathway in Epstein-Barr Virus-positive Gastric Cancer Cells.
Moon SH; Park NS; Noh MH; Kim YS; Cheong SH; Hur DY
Anticancer Res; 2022 Jan; 42(1):555-563. PubMed ID: 34969765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
